Sotera Health Company (SHC)

Market Cap	3.24B
Revenue (ttm)	1.11B
Net Income (ttm)	24.78M
Shares Out	283.86M
EPS (ttm)	0.09
PE Ratio	130.29
Forward PE	14.85
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,144,455
Open	11.60
Previous Close	11.75
Day's Range	11.36 - 11.69
52-Week Range	9.53 - 17.08
Beta	1.81
Analysts	Strong Buy
Price Target	16.00 (+40.35%)
Earnings Date	Aug 4, 2025

About SHC

Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets. The Nordion segment pr...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 20, 2020
• Employees: 3,000
• Stock Exchange: NASDAQ
• Ticker Symbol: SHC
• Website: https://soterahealth.com

Financial Performance

In 2024, Sotera Health Company's revenue was $1.10 billion, an increase of 4.88% compared to the previous year's $1.05 billion. Earnings were $44.34 million, a decrease of -13.21%.

Analyst Summary

According to 5 analysts, the average rating for SHC stock is "Strong Buy." The 12-month stock price target is $16.0, which is an increase of 40.35% from the latest price.

Price Target

$16.0

(40.35% upside)

Analyst Consensus: Strong Buy